T1? MRI AS A MARKER FOR NEUROFIBRILLARY TANGLES IN A MOUSE MODEL OF AD
T1? MRI AS A MARKER FOR NEUROFIBRILLARY TANGLES IN A MOUSE MODEL OF AD
批准号:
8361998
负责人:
ARI BORTHAKUR
金额:
$0.77万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-05-31
关键词:
A MouseAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-ProteinAnimalsAntibodiesBiochemicalBrainBreedingCell NucleusCodeColorDiagnosticFundingGrantHarvestHematoxylinHippocampus (Brain)Histological TechniquesHumanIACUCImageImmunohistochemistryMagnetic ResonanceMagnetic Resonance ImagingMapsMasksMeasuresMedialModelingMusMutationNational Center for Research ResourcesNeurofibrillary TanglesNeuronsPathologicPathologyPatientsPrincipal InvestigatorProtein IsoformsRelaxationReportingResearchResearch InfrastructureResourcesSliceSourceStaining methodStainsTemporal LobeTestingTimeTransgenic AnimalsTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthWeightWild Type Mouseagedbasebeta amyloid pathologycohortcostgray matterhyperphosphorylated taumouse modeloptical imagingtau Proteinstau-1white matter
中文摘要
这个子项目是利用资源的许多研究子项目之一。
由NIH/NCRR资助的中心拨款提供。对子项目的主要支持
子项目的首席调查员可能是由其他来源提供的,
包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能
表示该子项目使用的中心基础设施的估计数量,
不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。
AD小鼠模型模仿淀粉样β蛋白或过度磷酸化的tau病理,
阿尔茨海默病(AD)的尸检诊断标记物
使用生化和组织学技术。然而,唯一报道的MRI特征
在转基因AD小鼠模型上已经研究了淀粉样β蛋白的病理机制。松弛测量法
阿尔茨海默病患者T1?松弛时间的研究表明,T1?松弛时间相差8%
内侧颞叶白质松弛时间为5%,灰质松弛时间为5%。它是
假设T1?松弛时间常数对病理变化也很敏感
Tau蛋白导致细胞内病变引起的生化变化
神经原纤维缠结(NFTs)。为了验证这一假设,我们目前正在研究一组
在人tau亚型中表达P301S突变的转基因(TG)tau小鼠,以及
年龄匹配的野生型(WT)小鼠,进行T1?MRI检查。
所有的动物研究都得到了IACUC的批准。转基因动物是从PS19品系中选育出来的
P301S型号。瓦里安在9.4T小口径扫描仪上对老龄小鼠进行了MRI检查
13-15个月。在自旋锁定时间ts1=1,20,
30、40ms用于量化T1?松弛时间常数。四种MRI对比度分别是
在逐个像素的基础上进行指数拟合,以创建T1的颜色编码参数图
在每个像素上。在T1加权图像上手动绘制海马区和大脑皮层的ROI图
将TSL=1ms的图像和蒙版应用于T1?映射到的相应切片
测量平均T1?松弛时间。对PS19进行免疫组织化学染色
取小鼠脑后,以验证tau的病理程度。磷酸化tau的抗体被染成棕色,苏木素反染用于可视化。
神经元核团。
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
AD mouse models mimicking, either the amyloid-beta or hyperphosphorylated tau pathologies,
the post-mortem diagnostic markers of Alzheimer's disease (AD), have been characterized
using biochemical and histological techniques. However, the only MRI characterization reported
on transgenic mouse models of AD have studied the amyloid-beta pathology. A relaxometry
study of the T1¿ relaxation time in human AD patients showed a difference of 8% in the T1¿
relaxation times of white matter and 5% in gray matter of the medial temporal lobe. It is
hypothesized that the T1¿ relaxation time constant is also sensitive to the pathologic
biochemical changes resulting from pathology due to tau protein that leads to intracellular
neurofibrillary tangles (NFTs). To test this hypothesis, we are currently studying a cohort of
transgenic (Tg) tau mice expressing the P301S mutation in a human tau isoform, and
age-matched wild-type (WT) mice with T1¿ MRI.
All animal studies were approved by the IACUC. Tg animals were bred from the PS19 line of
the P301S model. MRI was performed on a 9.4T small-bore scanner by Varian on mice aged
13-15 months. Four T1¿-weighted images were obtained, at spin-locking times of TSL=1, 20,
30, 40ms for quantifying T1¿ relaxation time constant. The four MRI contrasts were
exponentially fit on a pixel-by-pixel basis to create a color-coded parametric map of the T1¿
at each pixel. ROIs of the hippocampus and cortex were manually drawn on T1¿-weighted
images at TSL=1ms, and masks were applied to the corresponding slices in the T1¿ maps to
measure the mean T1¿ relaxation times. Immunohistochemistry was performed on the PS19
mice after harvesting the brain in order to verify the extent of tau pathology. An antibody for phosphorylated tau stained brown and a counter-stain with hematoxylin were used to visualize
neuronal nuclei.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRI TECHNIQUES FOR SMALL ANIMAL NEURO-IMAGING
-
批准号:8361989
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2011
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI AS A QUANTITATIVE BIOMARKER OF DISC DEGENERATION IN VIVO
-
批准号:8361988
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2011
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI OF PATIENTS WITH ALZHEIMER?S DISEASE
-
批准号:8361953
-
项目类别:
-
资助金额:$3.08万
-
财政年份:2011
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI OF PATIENTS WITH PARKINSON?S DISEASE WITH AND WITHOUT DEMENTIA
-
批准号:8361980
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2011
-
负责人:ARI BORTHAKUR
-
依托单位:
A STUDY OF T1? VALUES IN ARTICULAR CARTILAGE OF ASYMPTOMATIC SUBJECTS
-
批准号:8169080
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2010
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI AS A QUANTITATIVE BIOMARKER OF DISC DEGENERATION IN VIVO
-
批准号:8169082
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2010
-
负责人:ARI BORTHAKUR
-
依托单位:
MRI TECHNIQUES FOR SMALL ANIMAL NEURO-IMAGING
-
批准号:8169083
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2010
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI OF PATIENTS WITH ALZHEIMER?S DISEASE
-
批准号:8169037
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2010
-
负责人:ARI BORTHAKUR
-
依托单位:
A METHOD FOR DE-SCALPING HUMAN BRAIN MRI DATA USING LIPID RATIO MAP
-
批准号:8169081
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2010
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI OF PATIENTS WITH ALZHEIMER?S DISEASE
-
批准号:7955307
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2009
-
负责人:ARI BORTHAKUR
-
依托单位:
DETECTION OF INTER-VERTEBRAL DISC DEGENERATION USING T1? MRI
-
批准号:7955337
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2009
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI OF PATIENTS WITH ALZHEIMER?S DISEASE
-
批准号:7723804
-
项目类别:
-
资助金额:$2.18万
-
财政年份:2008
-
负责人:ARI BORTHAKUR
-
依托单位:
IN VIVO CO-REGISTERED PROTON T1? AND SODIUM MRI OF THE HUMAN KNEE
-
批准号:7600817
-
项目类别:
-
资助金额:$2.75万
-
财政年份:2007
-
负责人:ARI BORTHAKUR
-
依托单位:
T1? MRI OF PATIENTS WITH ALZHEIMER?S DISEASE
-
批准号:7600813
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2007
-
负责人:ARI BORTHAKUR
-
依托单位:
IN VIVO ASSESSMENT OF HUMAN LUMBAR DISC DEGENERATION
-
批准号:7357867
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2006
-
负责人:ARI BORTHAKUR
-
依托单位:
FLUID-ATTENUATED T1RHO OF THE HUMAN BRAIN IN VIVO
-
批准号:7357868
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2006
-
负责人:ARI BORTHAKUR
-
依托单位:
T1RHO MRI OF THE HUMAN BRAIN USING A SPIN-LOCKED SSFP PULSE SEQUENCE
-
批准号:7357869
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2006
-
负责人:ARI BORTHAKUR
-
依托单位:
23NA MR IMAGING OF AN ALZHEIMER?S MOUSE MODEL AT 47T
-
批准号:7357871
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2006
-
负责人:ARI BORTHAKUR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: